The effect of low dose hormone therapy on mammographic breast density

Maturitas

Volumn 54, Issue 1, 2006, Pages 78-85

  Christodoulakos, George E ^a   Lambrinoudaki, Irene V ^a   Vourtsi, Athina D ^b   Vlachou, Sofia ^a   Creatsa, Maria ^a   Panoulis, Konstantinos P C ^a   Botsis, Dimitrios ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b Center of Radiation Oncology   (Greece)

Author keywords

Breast density; Low dose hormone therapy; Mammography

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ACETATE;

ADULT; AGED; ARTICLE; BREAST; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENSITY; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; BREAST; CONTRACEPTIVE AGENTS, FEMALE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; MAMMOGRAPHY; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; NORETHINDRONE; POSTMENOPAUSE;

EQUIDAE;

EID: 33645101084     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2005.08.012     Document Type: Article

References (51)

1. The North American Society Amended report the NAMS advisory panel on postmenopausal hormone therapy Menopause 10 2003 6 12
2. Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
3. J.C. Gallagher Role of estrogens in the management of postmenopausal bone loss Rheum Dis Clin North Am 27 2001 143 162
4. G.N. Koukoulis Hormone replacement therapy and breast cancer risk Ann NY Acad Sci 900 2000 422 428
5. G.A. Golditz Estrogen, estrogen plus progestin therapy and the risk of breast cancer Clin Cancer Res 11 2005 909s 917s
6. V. Beral, D. Bull, and R. Doll Breast cancer and hormone replacement therapy; collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer Lancet 350 1997 1047 1059
7. G.L. Anderson, M. Limacher, and A.R. Assaf Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial JAMA 291 2004 1701 1712
8. M.B. Laya, J.C. Gallagher, and J.S. Schreiman Effect of postmenopausal replacement therapy on mammographic density and parenchymal pattern Radiology 196 1995 433 437
9. E. Banks Hormone replacement therapy and the sensitivity and specificity of breast cancer screening: a review J Med Screen 8 2001 29 34
10. R.D. Rosenberg, W.C. Hunt, and N.R. Williamson Effects of age, breast density, ethnicity and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183134 screening mammograms in Albuquerque, New Mexico Radiology 209 1998 511 518
11. M.B. Laya, E.B. Larson, and S.H. Taplin Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography J Natl Cancer Inst 88 1996 643 649
12. M.E.L. Cohen Effect of hormone replacement therapy on cancer detection by mammography Lancet 349 1997 1624
13. E.E. Sterns, and B. Zee Mammographic density changes in perimenopausal and postmenopausal women: is effect of hormone replacement therapy predictable? Breast Cancer Res Tr 59 2000 125 132
14. R.C. Marugg, M.J. van der Mooren, and J.H.C.L. Hendriks Mammographic changes in postmenopausal women on hormonal replacement therapy Eur Radiol 7 1997 749 755
15. A.M. Kavanagh, H. Mitchell, and G.G. Giles Hormone replacement therapy and accuracy of mammographic screening Lancet 355 2000 270 274
16. L. Nyström, I. Andersson, J. Frisell, B. Nordensjold, and L.E. Rutqvist Long term effects of mammography screening: update overview of the Swedish randomized trials Lancet 359 2002 909 919
17. P.C. Stomper, D.J. D'Souza, P.A. DiNitto, and M.A. Arredonto Analysis of parenchymal density on mammograms in 1353 women 25-79 years old Am J Radiol 167 1996 1261 1265
18. I. Persson, E. Thurfjell, and L. Holmberg Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density J Clin Oncol 15 1997 3201 3207
19. C.M. Rutter, M.T. Mendelson, M.B. Laya, D.J. Seger, and S. Teplin Changes in breast density associated with initiation, discontinuation and continuing use of hormone replacement therapy JAMA 285 2001 171 176
20. E. Lundstrom, B. Wilczek, Z. von Palffy, G. Soderquist, and B. von Schoultz Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens Climacteric 4 2001 42 48
21. F.-P. Chen, Y.-C. Cheung, and L.-F. Teng The relationship between mammographic density and duration of hormone therapy: effects of estrogen and progestin Hum Reprod 20 6 2005 1741 1745
22. J.E. Berkowitz, O.M.B. Gatewood, L.E. Goldblum, and B.W. Gayler Hormonal replacement therapy: mammographic manifestations Radiology 174 1990 199 201
23. M.M.J. McNicholas, J.P. Heneghan, M.H. Milner, T. Tunney, J.B. Hourihane, and D.P. MacErlaine Pain and increased mammographic density in women receiving hormone replacement therapy: a prospective study Am J Radiol 163 1994 311 315
24. P.C. Stomper, B.J. vanVoorhis, V.A. Ravnikar, and J.E. Meyer Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study Radiology 174 1990 487 490
25. W. Leung, F. Goldberg, and B. Zee Analysis of parenchymal density on mammograms in 1353 women 25-79 years old Am J Radiol 167 1996 1261 1265
26. J.C. Litherland, S. Stollard, and D. Hole The effect of hormone replacement therapy on the sensitivity of screening mammograms Clin Radiol 54 1999 285 288
27. Z. Kaufmann, W.I.H. Garstin, R. Hayes, M.J. Michell, and M. Baum The mammographic parenchymal patterns of women on hormonal replacement therapy Clin Radiol 43 1991 389 392
28. G.A. Greendale, B.A. Reboussin, and A. Sie Effects of estrogen and estrogen-progestin on mammographic parenchymal density Ann Intern Med 130 1999 262 269
29. N. Colacurci, F. Fornaro, P. De Franciscis, D. Mele, M. Palermo, and W. delVecchio Effects of a short-term suspension of hormone replacement therapy on mammographic density Fertl Steril 76 2001 451 455
30. R. Warren Hormones and mammographic breast density Maturitas 49 2004 67 78
31. E. Lundstrom, B. Wilczek, and Z. von Palffy Mammographic breast density during hormone replacement therapy: differences according to treatment Am J Obstet Gynecol 181 2 1999 348 352
32. G.A. Greendale, B.A. Reboussin, and S. Slone Postmenopausal hormone therapy and change in mammographic density J Natl Cancer Inst 95 1 2003 30 37
33. G. Christodoulakos, I. Lambrinoudaki, and K. Panoulis The effect of various regimens of hormone replacement therapy on mammographic breast density Maturitas 45 2003 109 118
34. I. Valdivia, I. Campodonico, and A. Tapia Effects of tibolone and continuous combined hormone therapy on mammographic breast density and breast histochemical markers in postmenopausal women Fertil Steril 81 3 2004 617 623
35. E.B. Kilicdag, T. Bagis, and A. Pourbagher Hormone replacement therapy and mammographic density Int J Gyn Obstet 86 2004 56 58
36. R. Sitruk-Ware, and G. Plu-Bureau Exogenous progestagens and the human breast Maturitas 49 2004 58 66
37. P. Kenemans, and A. Bosman Breast cancer and postmenopausal hormone therapy Best Pract Res Clin Endocrinol Metab 17 2003 123 137
38. G. Söderqvist, and B. von Schoultz Lessons to be learned from clinical studies on hormones and the breast Maturitas 49 2004 90 96
39. E. Lundström, A. Christow, and G. Svane Effects of tibolone and a continuous combined HRT regimen on mammographic breast density Am J Obstet Gynecol 186 2002 717 722
40. P. Conner, G. Svane, and E. Azavedo Mammographic breast density, hormones and growth factors during continuous combined hormone therapy Fertil Steril 81 2004 1617 1623
41. 99mTc-sestamibi scintmammographic uptake in postmenopausal women on hormone replacement therapy Maturitas 53 1 2006 97 106
42. J.R. Pasqualini, J. Paris, and R. Sitruk-Ware Progestins and breast cancer J Steroid Biochem Mol Biol 65 1998 225 235
43. R. Druckmann Progestin and their effects on the breast Maturitas 46 S1 2003 S59 S69
44. North American Menopause Society Role of progestogen in hormone therapy for postmenopausal women: position statement of the North American Menopause Society Menopause 10 2003 113 132
45. R. Santen, J. Pinkeron, C. McCartney, and G.R. Petroni Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy J Clin Endocrinol Metab 86 2001 16 23
46. S.S.C. Yen, P.L. Martin, and A.M. Burnier Circulating estrdiol, estron and gonadotropin levels following the administration of orally active 17b-estradiol in postmenopausal women J Clin Endocrinol Metab 40 1975 518 521
47. D.F. Archer Lower doses of oral estrogen and progestogens as treatment for postmenopausal women Semin Reprod Med 23 2 2005 188 195
48. L. Speroff Postmenopausal hormone therapy and the risk of breast cancer. A clinician's view Maturitas 49 2004 51 57
49. H. Junkermann, T. von Holst, and E. Lang Influence of different HRT regimens on mammographic density Maturitas 50 2005 105 110
50. N.H. Bulbul, S. Ozden, and V. Dayicioglu Effects of hormone replacement therapy on mammographic findings Arch Gynecol Obstet 268 1 2003 5 8
51. L. Speroff The meaning of mammographic breast density in users of postmenopausal hormone therapy Maturitas 41 2002 171 175